Âé¶¹´«Ã½

Financing, Equity Capital Markets

Madrigal Pharmaceuticals, Inc.

09/23
|
$499.9 Million
Magrigal
Âé¶¹´«Ã½ served as bookrunner for Madrigal Pharmaceuticals, Inc. on a confidentially marketed follow-on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sector

Sub-Sector
Biopharma